Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Keeping our depressed patients in the right treatment long enough for them to get better: some hopeful findings.

Badaracco MA.

Am J Psychiatry. 2007 Aug;164(8):1136-9. No abstract available.

PMID:
17671271
2.

Comparing psychotherapy and pharmacotherapy for adult depression: adjusting for differential dropout rates.

Cuijpers P, van Straten A, van Oppen P, Andersson G.

J Clin Psychiatry. 2010 Sep;71(9):1246. doi: 10.4088/JCP.09l05891blu. No abstract available.

PMID:
20923628
3.

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

Laje G, Perlis RH, Rush AJ, McMahon FJ.

Psychiatr Serv. 2009 Nov;60(11):1446-57. doi: 10.1176/appi.ps.60.11.1446.

4.

Child psychopharmacology, effect sizes, and the big bang.

Mathews M, Adetunji B, Mathews J, Basil B, George V, Mathews M, Budur K, Abraham S.

Am J Psychiatry. 2005 Apr;162(4):818; author reply 818-9. No abstract available.

PMID:
15800177
5.

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.

Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, McMahon FJ.

Am J Psychiatry. 2007 Oct;164(10):1530-8.

PMID:
17898344
6.

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.

Paddock S, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ.

Am J Psychiatry. 2007 Aug;164(8):1181-8.

PMID:
17671280
7.

Genetic studies of drug response and side effects in the STAR*D study, part 2.

Garriock HA, Hamilton SP.

J Clin Psychiatry. 2009 Sep;70(9):1323-5. doi: 10.4088/JCP.09ac05522. No abstract available.

PMID:
19818256
8.

Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis.

Cuijpers P, Dekker J, Hollon SD, Andersson G.

J Clin Psychiatry. 2009 Sep;70(9):1219-29. doi: 10.4088/JCP.09r05021.

PMID:
19818243
9.

Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.

Laje G, Allen AS, Akula N, Manji H, John Rush A, McMahon FJ.

Pharmacogenet Genomics. 2009 Sep;19(9):666-74. doi: 10.1097/FPC.0b013e32832e4bcd.

10.

[After the pharmacology-driven euphoria--a new chance for developing and implementing of psychosocial interventions].

Richter D, Hoffmann H.

Psychiatr Prax. 2009 Nov;36(8):357-8. doi: 10.1055/s-0029-1223380. German. No abstract available.

PMID:
19916136
11.

Citalopram and the Curate's egg in geriatric depression.

Carroll BJ.

Am J Psychiatry. 2005 Sep;162(9):1762; author reply 1762-3. No abstract available.

PMID:
16135653
12.
13.

Clinical problem solving: the case of John, part I.

Drell MJ, Josephson A, Pleak R, Riggs P, Rosenfeld A.

J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1124-31. No abstract available.

PMID:
16926620
14.

The risk/benefit ratio of psychiatric treatment.

Oldham J.

J Psychiatr Pract. 2005 May;11(3):137. No abstract available.

PMID:
15920387
15.

Child psychopharmacology, effect sizes, and the big bang.

Barbe RP.

Am J Psychiatry. 2005 Apr;162(4):817-8; author reply 818-9. No abstract available.

PMID:
15800174
16.

Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberté MA, Abramson BL, Lambert J, Gravel G, Lespérance F.

Psychosom Med. 2006 Jan-Feb;68(1):87-93. Erratum in: Psychosom Med. 2007 Mar-Apr;69(2):216.

PMID:
16449416
17.

DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study.

Tsuchimine S, Yasui-Furukori N, Nakagami T, Sato Y, Kaneko S.

J Clin Psychopharmacol. 2012 Oct;32(5):724-6. doi: 10.1097/JCP.0b013e318267b6da. No abstract available.

PMID:
22926616
18.

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW.

Arch Gen Psychiatry. 2007 Jun;64(6):689-97.

PMID:
17548750
19.

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH.

Arch Gen Psychiatry. 2007 Jul;64(7):783-92.

PMID:
17606812
20.

An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results.

Schramm E, van Calker D, Dykierek P, Lieb K, Kech S, Zobel I, Leonhart R, Berger M.

Am J Psychiatry. 2007 May;164(5):768-77.

PMID:
17475736

Supplemental Content

Support Center